ABT vs TJX · P/E 25, rev $44.33B vs P/E 32, rev $29.50B
Abbott Laboratories (ABT) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the ABT and TJX stock pages for the full models.
Not investment advice.